𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine

✍ Scribed by M. T. Hyyppä; Vivi -Ann Långvik; U. K. Rinne

Publisher
Springer
Year
1978
Tongue
English
Weight
340 KB
Volume
42
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mortality of patients with parkinson's d
Mortality of patients with parkinson's disease treated with levodopa
✍ R. J. Marttila; U. K. Rinne; T. Siirtola; V. Sonninen 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 372 KB

The effect of levodopa on the mortality of patients with Parkinson's disease was investigated in 349 patients treated with levodopa or levodopa combined with decarboxylase inhibitor during 1969-1975 inclusive. During the study period, 61 patients died. The expected mortality was 32.99 resulting in a

Cysteine elevation in levodopa-treated p
Cysteine elevation in levodopa-treated patients with Parkinson's disease
✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract Homocysteine, cysteine, and cysteinyl‐glycine are all metabolically interrelated. Levodopa/decarboxylase inhibitor (LD/DCI) administration increases total homocysteine (tHcy) plasma levels. Objectives were to investigate associations between LD/DCI intake, concentrations of tHcy, cystei

Hyperhomocysteinemia in levodopa-treated
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia
✍ Stefano Zoccolella; Claudia dell'Aquila; Giovanni Abruzzese; Angelo Antonini; Ub 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract Dementia is a frequent non‐motor feature of Parkinson's disease (PD). Elevated plasma homocysteine (Hcy) levels have been associated with both cognitive impairment and dementia. Increased Hcy levels have been observed in levodopa‐treated patients with PD. The objective of our study was

Plasma profiles of adrenocorticotropic h
Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated parkinson's disease
✍ G. Bellomo; L. Santambrogio; M. Fiacconi; A. M. Scarponi; G. Ciuffetti 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 382 KB

Plasma profiles of prolactin, growth hormone, adrenocorticotropic hormone (ACTH) and cortisol were evaluated in a group of untreated patients with idiopathic Parkinson's disease and a group of healthy age-matched controls. Plasma integrated concentrations of all hormones except prolactin were signif